when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

LEADING · news · pharmadog

← back to LEADING

News mentioning LEADING

652 stories

Sep 21, 26Beyond Random Integration: Transposase cell line development shortening timeline & boosting titersbiospace

Sep 20, 26STAT+: Radiopharma companies merge after one receives surprise FDA rejectionstat

Sep 18, 26This week in charts: GSK’s China deals, the $300M IPO club and selling the newsbiopharma dive

Sep 18, 26Ultragenyx wins FDA greenlight for first Sanfilippo therapy, priced at nearly $4Mbiospace

Sep 18, 26Xenon pauses phase 3 depression trials after psychosis eventsfiercebiotech

Sep 18, 26Electra amasses $350M in biotech’s latest big IPObiopharma dive

Sep 17, 26Lisata deal propels Marea’s drug pipeline to Wall Streetbiopharma dive

Sep 17, 26Bristol Myers scraps $100M Orum-partnered cancer drugendpoints

Sep 17, 26Kennedy moves to revive preventive services panel with new members, after months of vacanciesstat

Sep 17, 26Longeveron’s shares crash as stem cell therapy flunks mid-stage cardio trialbiospace

Sep 17, 26Goa Therapeutics launches with ‘immeasurably huge’ vision of creating Narcan for alcoholfiercebiotech

Sep 17, 26Rare EGFR mutation increases lung cancer risk 62 times in never smokersfiercebiotech

Sep 17, 26Opinion: What happened to oppositional defiant disorder?stat

Sep 17, 26Longeveron’s phase 2b stem cell flop spurs cost cutting, exploration of ‘all options’fiercebiotech

Sep 16, 26Drugmakers cooperate with House probe of China trial sitesendpoints

Sep 16, 26Saratoga Potato Chips Issues Allergy Alert on Undeclared Soy in J. HIGGS Loaded Bacon and Cheddar Potato Chipsfda recalls

Sep 16, 26Deep dive: Psychedelics back on FDA’s doorstepbiospace

Sep 16, 26Why a US senator wants a biotech leader in the White House who ‘has the president’s ear’fiercebiotech

Sep 16, 26Novartis pays Sironax $125M to acquire platform for crossing the blood-brain barrierfiercebiotech

Sep 15, 26Gias Foods, Inc. Recalls Bettergoods Authentic Italian Lemon Alfredo Fettuccine Because of Possible Health Riskfda recalls

Sep 15, 26FDA approves first radioligand generic, setting up rivalry with Novartisendpoints

Sep 15, 26GSK lays off 650 staffers amid closure of German vaccine manufacturing sitebiospace

Sep 15, 26Businesses can now apply for NIH fundingstat

Sep 15, 26Exercise — and echocardiograms — in space protected astronauts’ hearts in studystat

Sep 15, 26Opinion: 3 lessons from the tobacco settlement on how states should use money from Metastat

Sep 15, 26J&J’s Contineum-partnered depression drug flunks another phase 2 testfiercebiotech

Sep 14, 26Cellectis quits CAR-T and pivots to ‘in vivo’ gene editingbiopharma dive

Sep 14, 26Scholar Rock SMA drug approved by FDAbiopharma dive

Sep 14, 26Lilly cans early experimental obesity drug after ‘high bar’ not metfiercebiotech

Sep 14, 26Axoltis misses the mark in phase 2 ALS study, but will persevere with the synthetic peptidefiercebiotech

← prevpage 7 of 22next →